|Dr. Albert Bourla D.V.M., DVM, Ph.D.||Chairman & CEO||5.84M||2.12M||1962|
|Mr. John D. Young||Group Pres & Chief Bus. Officer||3.36M||3.83M||1965|
|Mr. Frank A. D'Amelio||CFO & Exec. VP of Global Supply||3.84M||8.47M||1958|
|Dr. Mikael Dolsten||Chief Scientific Officer and Pres of Worldwide Research, Devel. & Medical||3.66M||7.93M||1959|
|Ms. Jennifer B. Damico||Sr. VP, Controller & Principal Accounting Officer||N/A||N/A||1968|
|Ms. Lidia L. Fonseca||Exec. VP and Chief Digital & Technology Officer||N/A||N/A||1969|
|Mr. Charles E. Triano||Sr. VP of Investor Relations||N/A||N/A||N/A|
|Mr. Douglas M. Lankler||Exec. VP & Gen. Counsel||N/A||N/A||1966|
|Mr. Rady A. Johnson||Exec. VP and Chief Compliance, Quality & Risk Officer||N/A||N/A||1962|
|Dr. Alexander Rod MacKenzie||Chief Devel. Officer & Exec. VP of Global Product Devel.||N/A||N/A||1960|
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., Myovant Sciences Ltd., Akcea Therapeutics, Inc, Verily Life Sciences LLC, Merck KGaA, Valneva SE, IDEAYA Biosciences, Inc., BioNTech SE, Jiangsu Alphamab Biopharmaceuticals Co., Ltd, BioInvent International AB, Sosei Group Corporation, LianBio, and Imcyse S.A. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Pfizer Inc.’s ISS Governance QualityScore as of December 3, 2020 is 2. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 1; Compensation: 1.